Schizophrenia Trial, Recruiting (NCT07176468)

Schizophrenia Trial, Recruiting NCT07176468 Sponsor: Anhui Medical University Condition: Schizophrenia

Printed from Voxsanity (voxsanity.com.au) — NCT07176468 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Schizophrenia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 60 years old, of any gender
People who have been diagnosed with schizophrenia according to the DSM-5 diagnostic guidelines
People whose antipsychotic medication was started, switched, or had its dose changed within the last 3 days
People who are able to understand what the study involves and sign a written consent form, and who are able to follow the study procedures and complete the required assessments

Who may not be able to join:

People who are currently experiencing thoughts of suicide or engaging in suicidal behaviour
People who have a major neurological condition, such as epilepsy, brain lesions, or a history of severe head injury
People for whom MRI scans or TMS (a type of brain stimulation) would not be safe, such as those with metal implants or a pacemaker
People who are pregnant or breastfeeding
People who have received TMS or ECT (electroconvulsive therapy) in the past 6 months
People whom the trial investigators determine to be unsuitable for participation for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0551 6516 7581

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07176468

Sponsor: Anhui Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Schizophrenia

Trial contact: 0551 6516 7581

More information: https://clinicaltrials.gov/study/NCT07176468

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 60 years old, of any gender
People who have been diagnosed with schizophrenia according to the DSM-5 diagnostic guidelines
People whose antipsychotic medication was started, switched, or had its dose changed within the last 3 days
People who are able to understand what the study involves and sign a written consent form, and who are able to follow the study procedures and complete the required assessments

Who may not be able to join:

People who are currently experiencing thoughts of suicide or engaging in suicidal behaviour
People who have a major neurological condition, such as epilepsy, brain lesions, or a history of severe head injury
People for whom MRI scans or TMS (a type of brain stimulation) would not be safe, such as those with metal implants or a pacemaker
People who are pregnant or breastfeeding
People who have received TMS or ECT (electroconvulsive therapy) in the past 6 months
People whom the trial investigators determine to be unsuitable for participation for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Anhui Medical University

Registry

ClinicalTrials.gov

Start date

20 October 2025

Est. completion

20 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The Positive and Negative Syndrome Scale (PANSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov